Triazole antifungal
Itraconazole
Brand names: Sporanox
Adult dose
Dose: Onychomycosis pulse: 200mg BD for 1 week, repeat after 21 days. Aspergillosis: 200mg OD-BD
Route: PO/IV
Frequency: OD-BD
Clinical pearls
- Take capsules WITH food (acidic environment); solution on EMPTY stomach
- Therapeutic drug monitoring in invasive infection
Contraindications
- Heart failure (incl. hx)
- Severe hepatic impairment
- Pregnancy
- Concurrent QT-prolonging drugs / ergot / many CYP3A4 substrates
Side effects
- Heart failure (negative inotrope — black box)
- Hepatotoxicity
- QT prolongation
- Hypokalaemia
- Peripheral neuropathy
Interactions
- Strong CYP3A4 inhibition — many
- Statins (myopathy)
- Quinidine/cisapride/dofetilide (avoid)
- Tacrolimus/ciclosporin (raised)
- Warfarin
Monitoring
- LFTs
- Trough levels (invasive infection)
Reference: BNF; MHRA Drug Safety Update; https://bnf.nice.org.uk/drugs/itraconazole/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023